Company registration number 11623152 (England and Wales)
KOGS MEDICAL CONSULTANCY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024
PAGES FOR FILING WITH REGISTRAR
Company Registration No. 11623152
KOGS MEDICAL CONSULTANCY LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2024
31 October 2024
- 1 -
2024
2023
£
£
£
£
Called up share capital not paid
5
5
Fixed assets
2,630
3,094
Current assets
445,327
389,304
Creditors: amounts falling due within one year
(20,530)
(18,572)
Net current assets
424,797
370,732
Total assets less current liabilities
427,432
373,831
Accruals and deferred income
(6,750)
(4,134)
Net assets
420,682
369,697
Capital and reserves
420,682
369,697
Notes to the financial statements
1
Directors' benefits: advances, credit and guarantees

At the year end the directors owed the company a balance amounting to £76,855 (2023 - £75,164). During the year amounts advanced to the directors were £nil (2023 - £894) and interest of £1,691 (2023 - £1,580) was charged on the loan. The loan is repayable on demand and interest is charged at the HMRC official rate of interest.

2
Employees

The average number of persons, including directors, employed by the company during the year was as follows:

2024
2023
Number
Number
Employees
3
3
Company Registration No. 11623152
KOGS MEDICAL CONSULTANCY LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 OCTOBER 2024
31 October 2024
- 2 -

KOGS Medical Consultancy Limited is a private company limited by shares incorporated in England and Wales. The registered office is 117 Coleridge Way, Borehamwood, United Kingdom, WD6 2AF.

For the year ended 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 29 July 2025 and are signed on its behalf by:
Dr G Da-Silva
Director
2024-10-312023-11-01falseCCH SoftwareCCH Accounts Production 2024.210No description of principal activityDr G Da-SilvaDr S Da-Silvafalsefalse116231522023-11-012024-10-31116231522024-10-31116231522023-10-3111623152core:CurrentFinancialInstrumentscore:WithinOneYear2024-10-3111623152core:CurrentFinancialInstrumentscore:WithinOneYear2023-10-31116231522022-11-012023-10-3111623152bus:Director12023-11-012024-10-3111623152bus:PrivateLimitedCompanyLtd2023-11-012024-10-3111623152bus:SmallCompaniesRegimeForAccounts2023-11-012024-10-3111623152bus:Micro-entities2023-11-012024-10-3111623152bus:AuditExemptWithAccountantsReport2023-11-012024-10-3111623152bus:Director22023-11-012024-10-3111623152bus:FullAccounts2023-11-012024-10-31xbrli:purexbrli:sharesiso4217:GBP